Guidant's Non-Randomized Ancure AAA Study Acceptable, Panel Concludes

Guidant's Ancure tube and bifurcated endovascular graft systems for abdominal aortic aneurysm (AAA) treatment have 19.6% and 28.7% respective rates of operative adverse events compared with 44.1% for surgical repair, according to data from the firm's pivotal clinical trial.